SG11202007274UA - Multifunctional treatment and diagnostic compositions and methods - Google Patents
Multifunctional treatment and diagnostic compositions and methodsInfo
- Publication number
- SG11202007274UA SG11202007274UA SG11202007274UA SG11202007274UA SG11202007274UA SG 11202007274U A SG11202007274U A SG 11202007274UA SG 11202007274U A SG11202007274U A SG 11202007274UA SG 11202007274U A SG11202007274U A SG 11202007274UA SG 11202007274U A SG11202007274U A SG 11202007274UA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- diagnostic compositions
- multifunctional treatment
- multifunctional
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2018/024338 WO2019190459A1 (en) | 2018-03-26 | 2018-03-26 | Multifunctional treatment and diagnostic compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202007274UA true SG11202007274UA (en) | 2020-08-28 |
Family
ID=68059517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202007274UA SG11202007274UA (en) | 2018-03-26 | 2018-03-26 | Multifunctional treatment and diagnostic compositions and methods |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11324826B2 (en) |
| EP (1) | EP3773561A4 (en) |
| CA (1) | CA3089809A1 (en) |
| SG (1) | SG11202007274UA (en) |
| WO (1) | WO2019190459A1 (en) |
| ZA (1) | ZA202005436B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102019102839A1 (en) * | 2019-02-05 | 2020-08-06 | Olympus Winter & Ibe Gmbh | Irrigation fluid for resection |
| DE102019102841A1 (en) | 2019-02-05 | 2020-08-06 | Olympus Winter & Ibe Gmbh | Detachable insulating insert for use in a resectoscope |
| WO2021086312A1 (en) * | 2019-10-28 | 2021-05-06 | Salazar Jennie | Reduced adaptive microbial resistance treatment for flesh eating disease |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030082101A1 (en) * | 2001-06-11 | 2003-05-01 | Cavalier Discovery | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species |
| EP1778616A1 (en) * | 2004-08-09 | 2007-05-02 | Cancer Research Technology Limited | Alpha-ketoglutarates and their use as therapeutic agents |
| US9339485B2 (en) | 2007-03-02 | 2016-05-17 | University Of Maryland, Baltimore County | Plasmonic engineering of singlet oxygen and/or superoxide generation |
| US7776614B2 (en) | 2007-08-09 | 2010-08-17 | Hallstar Innovations Corp. | Test method for determining compounds capable of quenching electronic singlet state excitation of photoactive compounds |
| JP5190865B2 (en) * | 2007-08-23 | 2013-04-24 | 国立大学法人九州大学 | Brominated porphycene derivative and photodynamic therapeutic agent containing the same |
| US8182785B2 (en) | 2008-06-11 | 2012-05-22 | Nutech Ventures | Methods and compositions for generating singlet oxygen |
| US9339557B2 (en) | 2009-10-08 | 2016-05-17 | National Cancer Center | Photosensitizer-metal nanoparticle complex and composition containing the complex for photodynamic therapy or diagnosis |
| US8609837B2 (en) | 2010-07-06 | 2013-12-17 | Health Research, Inc. | Metallation enhancements in tumor-imaging and PDT therapy |
| US9694075B2 (en) | 2011-04-08 | 2017-07-04 | Sanovas, Inc. | Treatment of hypoxic tumors with localized oxygenation |
| JP5854407B2 (en) | 2011-05-06 | 2016-02-09 | 国立大学法人東京工業大学 | Photodynamic therapy or diagnostic agent with infrared light |
| US9345904B2 (en) | 2011-07-01 | 2016-05-24 | Sbi Pharmaceuticals Co., Ltd. | Photodynamic therapy using photosensitizing agent or 5-aminolevulinic acid |
| WO2013019975A1 (en) | 2011-08-03 | 2013-02-07 | University Of Iowa Research Foundation | Compositions and methods of treating cancer |
| DE102011116165A1 (en) * | 2011-10-14 | 2013-04-18 | Merck Patent Gmbh | Benzodioxepin-3-one compounds |
| WO2013163321A1 (en) | 2012-04-24 | 2013-10-31 | You Youngjae | Singlet oxygen-labile linkers and methods of production and use thereof |
| US9867800B2 (en) | 2012-08-10 | 2018-01-16 | Hallstar Innovations Corp. | Method of quenching singlet and triplet excited states of pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds have electron withdrawing groups, to reduce generation of reactive oxygen species, particularly singlet oxygen |
| US9145383B2 (en) | 2012-08-10 | 2015-09-29 | Hallstar Innovations Corp. | Compositions, apparatus, systems, and methods for resolving electronic excited states |
| EP3210626A1 (en) | 2016-02-26 | 2017-08-30 | biolitec Unternehmensbeteiligungs II AG | Conjugates of porphyrinoid photosensitizers and glycerol-based polymers for photodynamic therapy |
-
2018
- 2018-03-26 US US16/616,437 patent/US11324826B2/en active Active
- 2018-03-26 CA CA3089809A patent/CA3089809A1/en active Pending
- 2018-03-26 EP EP18913108.9A patent/EP3773561A4/en active Pending
- 2018-03-26 WO PCT/US2018/024338 patent/WO2019190459A1/en active Search and Examination
- 2018-03-26 SG SG11202007274UA patent/SG11202007274UA/en unknown
-
2020
- 2020-08-31 ZA ZA2020/05436A patent/ZA202005436B/en unknown
- 2020-12-22 US US17/130,819 patent/US20210177970A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019190459A1 (en) | 2019-10-03 |
| ZA202005436B (en) | 2023-02-22 |
| US11324826B2 (en) | 2022-05-10 |
| US20210177970A1 (en) | 2021-06-17 |
| US20200121791A1 (en) | 2020-04-23 |
| EP3773561A1 (en) | 2021-02-17 |
| CA3089809A1 (en) | 2019-10-03 |
| EP3773561A4 (en) | 2021-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268406A (en) | Compositions and methods for the treatment of hemoglobinopathies | |
| HK1258205A1 (en) | Compositions and methods for the treatment of hemoglobinopathies | |
| HK1253769A1 (en) | Methods and compositions for the diagnosis and for the treatment of adrenoleukodystrophy | |
| GB201701805D0 (en) | Dental treatment appliance | |
| EP3337465A4 (en) | Compositions and methods for use in combination for the treatment and diagnosis of autoimmune diseases | |
| IL273959A (en) | Methods and compositions for the treatment of rare diseases | |
| IL276808A (en) | Compositions and methods for cancer treatment | |
| ZA202006610B (en) | Compositions for the treatment of skin conditions | |
| ZA202007055B (en) | Compositions for the treatment of skin conditions | |
| IL290150A (en) | Compositions and methods for the treatment of chronic pain | |
| ZA202005436B (en) | Multifunctional treatment and diagnostic compositions and methods | |
| IL272937A (en) | Compositions and methods for the treatment of fibrotic diseases | |
| EP3368048A4 (en) | Methods and compositions for the treatment of amyloidosis | |
| SG11202009382WA (en) | Dental treatment appliance | |
| SG11201705524SA (en) | Compositions and methods for the treatment of inflammation and pain | |
| SG11202009383TA (en) | Dental treatment appliance | |
| EP3706767A4 (en) | Compositions and methods for the treatment of allergy | |
| GB2575023B (en) | Dental treatment appliance | |
| GB201810151D0 (en) | Dental treatment appliance | |
| IL274588A (en) | Methods and compositions for the improvement of lysosomal function and treatment of neurodegenerative disease | |
| IL272147A (en) | Methods and compositions for the treatment of cancer | |
| GB201811744D0 (en) | Dental treatment appliance | |
| IL280262A (en) | Compositions and methods for the treatment of cancer | |
| IL276228A (en) | Compounds and compositions for the treatment of pain | |
| GB201908076D0 (en) | Skin treatment composition |